Breaking News
Get 45% Off 0
🌊 NVIDIA ripple effect: Track AI stocks' response to chip giant's earnings
Explore AI Stocks

Zacks Investment Research Zacks Investment Research

Zacks Investment Research's Opinion & Analysis.
Featured here: a complete archive of all posts and research produced by Zacks Investment Research, including current material.
First Solar (FSLR) Gains As Market Dips: What You Should Know By Zacks Investment Research - Mar 20, 2020

First Solar (NASDAQ:FSLR) closed the most recent trading day at $33.69, moving +0.69% from the previous trading session. The stock outpaced the S&P 500's daily loss of 4.34%. At the same time, the...

Soft Commodity ETFs Showing Better Resistance To Virus By Zacks Investment Research - Mar 20, 2020

In the past month, Wall Street has been on a freefall with key U.S. indexes entering a bear market territory due to the coronavirus outbreak and the oil-price war. While there are very few corners...

The Market's Worst Days Are Behind Us By Zacks Investment Research - Mar 20, 2020

The chart below shows the year-to-date performance of the S&P 500, Nasdaq Composite and the Russell 2000 indexes. Please note that the Russell 2000’s underperformance is primarily...

"Cash Is King:" Buy These Tech ETFs To Beat Coronavirus By Zacks Investment Research - Mar 20, 2020

Wall Street has been witnessing a brutal selloff this month, thanks to the coronavirus-led economic fallout. Major indexes are now in the bear market territory, having fallen at least 25% from their...

3 Reasons Growth Investors Will Love SAIC (SAIC) By Zacks Investment Research - Mar 20, 2020

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find...

3 Reasons Why Growth Investors Shouldn't Overlook BMC (BMCH) By Zacks Investment Research - Mar 20, 2020

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great...

Diamondback Trims 2020 Capital Budget, Lowers Output View By Zacks Investment Research - Mar 20, 2020

Diamondback Energy, Inc. (NASDAQ:FANG) recently announced its plan to trim its 2020 capex guidance by $1.2 billion (or in excess of 40%) to the tune of $1.5-$1.9 billion from its prior guidance of...

Here's Why You Should Hold On To JPMorgan Despite Rate Cut By Zacks Investment Research - Mar 20, 2020

Amid the current market turmoil, people are shying away from investing in equity markets, more so in banking stocks. Several factors, including the Federal Reserve’s accelerated move to cut...

5 ETFs In Green Despite The Coronavirus-Driven Sell-Off By Zacks Investment Research - Mar 20, 2020

COVID-19 has been hurting economy worldwide, leading to bloodbath across the global market. In fact, the outbreak has ended the longest ever 11-year bull market and sent the stocks into a deep bear...

Gilead's HCV Drug Epclusa Gets FDA Nod For Expanded Age Group By Zacks Investment Research - Mar 20, 2020

Gilead Sciences, Inc. (NASDAQ:GILD) announced that the FDA has approved the supplemental new drug application (sNDA) to update its hepatitis C infection (HCV) drug, Epclusa’s label. The sNDA...

Continue with Apple
Continue with Google
or
Sign up with Email